Add BrightSurf on Google Email

Science News for February 22, 2007


What is wrong with intelligent design?

A philosopher argues that intelligent design lacks testability due to the inability of observations to discriminate between ID claims and competing theories. He also points out that criticism of evolution is not a sufficient test for ID, and auxiliary assumptions about the designer's goals are not independently justified.

SourceUniversity of Chicago Press Journals·JournalThe Quarterly Review of Biology·DateFeb 22, 2007

JCI table of contents -- February 22, 2006

Researchers have identified potential new treatments for three serious diseases: a drug that increases SMN production in mice with spinal muscular atrophy, overexpression of Akt that converts a less invasive to a highly invasive melanoma, and inhibition of PKC-epsilon that prevents insulin resistance in non-alcoholic fatty liver disease

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 22, 2007

How stem cells are regulated

Researchers identified Jumonji proteins essential for cellular differentiation, inactivating genes critical to embryogenesis. The study uses C. elegans and mouse embryonic stem cells, with potential applications in cancer treatment using inhibitors.

SourceUniversity of Copenhagen·JournalCell·DateFeb 22, 2007

Alcohol interventions that teach practical skills work best with high-risk university students

A new Swedish study reveals that university students engaging in high-risk alcohol consumption benefit most from a skills-training program. The program, which combines cognitive-skill intervention and motivational techniques, was found to be more effective than other interventions in reducing alcohol consumption among at-risk students.

Scientists produce neurons from human skin

Researchers successfully produced neurons in vitro using stem cells from adult human skin, a breakthrough that could lead to revolutionary advances in treating neurodegenerative diseases like Parkinson's. The method used involves extracting neuron precursor cells from skin samples and cultivating them in an appropriate environment.

SourceUniversité Laval·JournalJournal of Cellular Physiology·DateFeb 22, 2007

Drug blocks lethal motor-neuron disease in mice

A study shows that trichostatin A, a hydroxamic acid HDAC inhibitor, increases SMN2 production in both neural tissues and muscles of mice with spinal muscular atrophy, improving survival chances. The treatment attenuates disease symptoms in affected mice.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 22, 2007

Pigs arrived in biosecure facility

Spring Point Project's biosecure animal facility has successfully bred high-health, pathogen-free pigs, paving the way for potential human islet cell transplantation. The goal is to provide an FDA-approved standard treatment soon after clinical trials within three years.

Killing the messenger RNA -- But which one?

Researchers at The Wistar Institute discovered that microRNAs can undergo molecular editing, redirecting them to target and silence entirely different sets of genes. This process has significant physiological consequences, such as altering the production of essential enzymes involved in synthesizing uric acid.

SourceThe Wistar Institute·JournalScience·DateFeb 22, 2007

Peanut-shaped nanostructures

Japanese scientists produce peanut-shaped nanoparticles comprising two different sulfur-containing substances, palladium sulfide and cobalt sulfide. The unique structure gives rise to different physical and chemical properties.

SourceWiley·DateFeb 22, 2007